Scott Parker

2.5k total citations
42 papers, 1.7k citations indexed

About

Scott Parker is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, Scott Parker has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Virology, 31 papers in Epidemiology and 18 papers in Molecular Biology. Recurrent topics in Scott Parker's work include Herpesvirus Infections and Treatments (26 papers), Poxvirus research and outbreaks (26 papers) and Bacillus and Francisella bacterial research (16 papers). Scott Parker is often cited by papers focused on Herpesvirus Infections and Treatments (26 papers), Poxvirus research and outbreaks (26 papers) and Bacillus and Francisella bacterial research (16 papers). Scott Parker collaborates with scholars based in United States, United Kingdom and Brazil. Scott Parker's co-authors include R. Mark L. Buller, Denise Schultz, Anthony A. Nuara, Eric Hunter, Jill Schriewer, George R. Painter, Randall Lanier, Alice Robertson, Robert Jordan and Dennis E. Hruby and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Scott Parker

41 papers receiving 1.7k citations

Peers

Scott Parker
Eric M. Mucker United States
Heinz Weidenthaler United States
Michael Merchlinsky United States
Tilahun Yilma United States
Janice C. Knight United States
Eric M. Mucker United States
Scott Parker
Citations per year, relative to Scott Parker Scott Parker (= 1×) peers Eric M. Mucker

Countries citing papers authored by Scott Parker

Since Specialization
Citations

This map shows the geographic impact of Scott Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Parker more than expected).

Fields of papers citing papers by Scott Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Parker. The network helps show where Scott Parker may publish in the future.

Co-authorship network of co-authors of Scott Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Parker. A scholar is included among the top collaborators of Scott Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Parker. Scott Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Scott, June Ann D’Angelo, R. Mark L. Buller, et al.. (2021). A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge. Antiviral Research. 195. 105179–105179. 22 indexed citations
2.
Oliveira, Leonardo Camilo de, Jonas D. Albarnaz, Alice A. Torres, et al.. (2020). The small molecule AZD6244 inhibits dengue virus replication in vitro and protects against lethal challenge in a mouse model. Archives of Virology. 165(3). 671–681. 13 indexed citations
3.
Ananthula, Hari Krishna, Scott Parker, R. Mark L. Buller, et al.. (2018). Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents. BMC Pharmacology and Toxicology. 19(1). 80–80. 12 indexed citations
4.
Korom, Maria, et al.. (2016). Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox. Antiviral Research. 139. 112–116. 12 indexed citations
5.
Franceschi, Valentina, Scott Parker, Konstantin Doronin, et al.. (2015). BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge. PLoS neglected tropical diseases. 9(6). e0003850–e0003850. 42 indexed citations
6.
Matho, Michael H., Xiangzhi Meng, Mohammed Rafii‐El‐Idrissi Benhnia, et al.. (2015). Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer. PLoS Pathogens. 11(9). e1005148–e1005148. 45 indexed citations
8.
Parker, Scott, Scott A. Foster, E. Randall Lanier, et al.. (2014). Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus. Antiviral Research. 111. 42–52. 20 indexed citations
9.
Buuren, Nicholas van, et al.. (2014). EVM005: An Ectromelia-Encoded Protein with Dual Roles in NF-κB Inhibition and Virulence. PLoS Pathogens. 10(8). e1004326–e1004326. 19 indexed citations
10.
Wright, Jennifer G., Brian D. Plikaytis, Charles E. Rose, et al.. (2013). Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trial. Vaccine. 32(8). 1019–1028. 29 indexed citations
11.
Pajewski, Nicholas M., Sadeep Shrestha, Conrad P. Quinn, et al.. (2012). A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed. Vaccine. 30(32). 4778–4784. 20 indexed citations
12.
Esteban, David J., et al.. (2012). Mousepox, A Small Animal Model of Smallpox. Methods in molecular biology. 890. 177–198. 22 indexed citations
13.
Denzler, Karen L., Jill Schriewer, Scott Parker, et al.. (2011). The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus. Vaccine. 29(52). 9691–9696. 9 indexed citations
14.
Chen, Nanhai G., Clifford J. Bellone, Jill Schriewer, et al.. (2010). Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: Pathogenesis, prophylaxis, and antiviral therapy. Virology. 409(2). 328–337. 33 indexed citations
15.
Buller, R. Mark L., et al.. (2009). The new ACAM2000™ vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks. Expert Review of Vaccines. 8(7). 841–850. 28 indexed citations
16.
Parker, Scott, Akbar M. Siddiqui, Randall Lanier, et al.. (2008). Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies. Virology. 385(1). 11–21. 41 indexed citations
17.
Parker, Scott, Anthony A. Nuara, R. Mark L. Buller, & Denise Schultz. (2007). Human Monkeypox: An Emerging Zoonotic Disease. Future Microbiology. 2(1). 17–34. 240 indexed citations
18.
Parker, Scott, Scott T. Rottinghaus, Allan Zajac, et al.. (2007). HIV-189.6 Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice. Vaccine. 25(37-38). 6764–6773. 7 indexed citations
19.
Sakalian, Michael, Scott Parker, Robert Weldon, & Eric Hunter. (1996). Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro. Journal of Virology. 70(6). 3706–3715. 60 indexed citations
20.
Tappero, Jordan W., Joseph Bresee, C. J. Peters, et al.. (1994). Hantavirus Pulmonary Syndrome in California: Report of Two Cases and Investigation. Clinical Infectious Diseases. 19(6). 1105–1109. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026